IL-17 as a Potential Target for Modulating Airway Neutrophilia
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1855-1861
Author(s):
Martti Laan and Anders Linden
Strontium Ranelate in Osteoporosis
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1907-1916
Author(s):
J.- Y. Reginster
Gene Therapy Approaches for the Selective Killing of Cancer Cells
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1683-1694
Author(s):
Eva Maria Westphal and Harald von Melchner
Epothilones: A Novel Class of Non-taxane Microtubule-stabilizing Agents
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1707-1712
Author(s):
Ramin Altaha, Tito Fojo, Eddie Reed and Jame Abraham
Immune Modulation by Ionizing Radiation and its Implications for Cancer Immunotherapy
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1765-1780
Author(s):
Eric J. Friedman
Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.
Journal:
Current Gene Therapy
Volume:
2
Page:
307-322
Author(s):
Ingrid J. van Dillen, Nanno H. Mulder, Willem Vaalburg, Erik F.J. de Vries and Geke A.P. Hospers
Transductional Targeting with Recombinant Adenovirus Vectors
Journal:
Current Gene Therapy
Volume:
2
Page:
323-339
Author(s):
Valerie Legrand, Philippe Leissner, Arend Winter, Majid Mehtali and Monika Lusky
Gene Therapy Strategies to Prevent Autoimmune Disorders
Journal:
Current Gene Therapy
Volume:
2
Page:
341-354
Author(s):
Massimo Trucco, Paul D. Robbins, Angus W. Thomson and Nick Giannoukakis
Polycistronic Viral Vectors
Journal:
Current Gene Therapy
Volume:
2
Page:
355-378
Author(s):
P. de Felipe
Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors
Journal:
Current Gene Therapy
Volume:
2
Page:
379-392
Author(s):
O. Mazda